Michael J. Fox Foundation Awards $1.9 Million for Development of Non-Invasive Neuroimaging Techniques in Living Brain
This program was funded with a lead gift from The Edmond J. Safra Foundation in memory of its founder, Mr.
Funded projects are listed below. Detailed information, including grant abstracts and researcher bios, is available on the Foundation's Searchable Database of Funded Grants.
As with all MJFF grants, full funding is dependent on the achievement of predetermined, specific milestones and on researchers' agreement to make the results of their work available to the Parkinson's research community.
Development and Screening of Contrast Agents for In Vivo Imaging of PD
Utility of the Amyloid Ligand [18F] FDDNP in Human PET Imaging in Parkinson's Disease
18F-labeled Alpha-Synuclein Ligands for PET Imaging of Lewy Bodies
Generation of Alpha-Synuclein Conformation-specific Aptamers for In Vivo Bioimaging of Alpha-Synuclein Pathology
A Strategy to Develop a Radiotracer Targeting Alpha-Synuclein
In Vivo SPECT Imaging of Synuclein Aggregation with Morphology-specific Antibody-based Ligands
About The Michael J. Fox Foundation
Founded in 2000, The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease within the coming decade through an aggressively funded research agenda. The Foundation has funded about
Considered by many to have been among the greatest bankers of his generation,
SOURCE The Michael J. Fox Foundation for Parkinson's Research
More by this Source
The Michael J. Fox Foundation Unites Industry Groups around Research Tool Development
Sep 13, 2013, 07:00 ET
The Michael J. Fox Foundation Hosts First Clinical Trials Fair in Chicago
Sep 06, 2013, 10:20 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.